IDEXX Laboratories, Inc. (0J8P.L)
0J8P.L Stock Price Chart
Explore IDEXX Laboratories, Inc. interactive price chart. Choose custom timeframes to analyze 0J8P.L price movements and trends.
0J8P.L Company Profile
Discover essential business fundamentals and corporate details for IDEXX Laboratories, Inc. (0J8P.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Equipment & Services
IPO Date
19 Jan 2018
Employees
11.00K
Website
https://www.idexx.comCEO
Jonathan J. Mazelsky
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
0J8P.L Financial Timeline
Browse a chronological timeline of IDEXX Laboratories, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 29 Apr 2026
Upcoming earnings on 2 Feb 2026
Upcoming earnings on 29 Oct 2025
Upcoming earnings on 4 Aug 2025
Revenue estimate is $1.06B.
Earnings released on 1 May 2025
EPS came in at $2.96 surpassing the estimated $2.85 by +3.86%, while revenue for the quarter reached $998.43M, missing expectations by -5.83%.
Earnings released on 3 Feb 2025
EPS came in at $2.62 surpassing the estimated $2.40 by +9.17%, while revenue for the quarter reached $954.29M, missing expectations by -4.88%.
Earnings released on 31 Oct 2024
EPS came in at $2.80 surpassing the estimated $2.68 by +4.48%, while revenue for the quarter reached $975.54M, missing expectations by -0.49%.
Earnings released on 6 Aug 2024
EPS came in at $2.44 falling short of the estimated $2.88 by -15.28%, while revenue for the quarter reached $1.00B, missing expectations by -0.31%.
Earnings released on 1 May 2024
EPS came in at $2.81 surpassing the estimated $2.71 by +3.69%, while revenue for the quarter reached $964.10M, missing expectations by -0.03%.
Earnings released on 4 Mar 2024
EPS came in at $2.32 surpassing the estimated $2.12 by +9.43%, while revenue for the quarter reached $901.60M, beating expectations by +1.09%.
Earnings released on 1 Nov 2023
EPS came in at $2.53 surpassing the estimated $2.37 by +6.75%, while revenue for the quarter reached $915.53M, missing expectations by -1.23%.
Earnings released on 1 Aug 2023
EPS came in at $2.67 surpassing the estimated $2.47 by +8.10%, while revenue for the quarter reached $943.63M, beating expectations by +0.97%.
Earnings released on 2 May 2023
EPS came in at $2.55 surpassing the estimated $2.42 by +5.37%, while revenue for the quarter reached $900.20M, beating expectations by +1.07%.
Earnings released on 6 Feb 2023
EPS came in at $2.05 surpassing the estimated $1.92 by +6.77%, while revenue for the quarter reached $828.57M, beating expectations by +0.93%.
Earnings released on 30 Sept 2022
EPS came in at $2.15 surpassing the estimated $2.05 by +4.88%, while revenue for the quarter reached $841.66M, beating expectations by +1.40%.
Earnings released on 30 Jun 2022
EPS came in at $1.56 matching the estimated $1.56, while revenue for the quarter reached $860.55M, missing expectations by -0.30%.
Earnings released on 31 Mar 2022
EPS came in at $2.27 surpassing the estimated $2.25 by +0.89%, while revenue for the quarter reached $836.55M, missing expectations by -0.07%.
Earnings released on 2 Feb 2022
EPS came in at $1.89 surpassing the estimated $1.72 by +9.88%, while revenue for the quarter reached $801.09M, beating expectations by +2.46%.
Earnings released on 2 Nov 2021
EPS came in at $2.34, while revenue for the quarter reached $826.14M.
Earnings released on 30 Sept 2021
EPS came in at $2.03, while revenue for the quarter reached $810.42M.
Earnings released on 31 Mar 2021
EPS came in at $2.35, while revenue for the quarter reached $777.71M.
Earnings released on 31 Dec 2020
EPS came in at $2.01, while revenue for the quarter reached $720.94M.
Earnings released on 30 Sept 2020
EPS came in at $1.69, while revenue for the quarter reached $721.79M.
0J8P.L Stock Performance
Access detailed 0J8P.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.